Lyka Labs

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE933A01014
  • NSEID: LYKALABS
  • BSEID: 500259
INR
69.95
-3.05 (-4.18%)
BSENSE

Feb 03

BSE+NSE Vol: 94.46 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy
Comparison
Company
Score
Quality
Valuation
Financial
Technical
Syschem (India)
BDH Industries
Bafna Pharma.
Zenotech Lab.
Gennex Lab.
Sanjiv.Parant.
Ambalal Sarabhai
Nectar Lifesci.
Kerala Ayurveda
Lyka Labs
Sat Kartar
Why is Lyka Labs Ltd ?
1
High Debt Company with a Debt to Equity ratio (avg) at 2.98 times
  • Poor long term growth as Net Sales has grown by an annual rate of 14.82% over the last 5 years
  • High Debt Company with a Debt to Equity ratio (avg) at 2.98 times
  • PBT LESS OI(Q) At Rs -5.47 cr has Fallen at -307.20%
  • PAT(Q) At Rs -3.36 cr has Fallen at -260.0%
  • NET SALES(Q) At Rs 36.66 cr has Fallen at -10.93%
2
Below par performance in long term as well as near term
  • Along with generating -50.12% returns in the last 1 year, the stock has also underperformed BSE500 in the last 3 years, 1 year and 3 months
stock-recommendationReal-Time Research Report
Verdict Report
How much should you sell?
  1. All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is Lyka Labs for you?

High Risk, Low Return

Absolute
Risk Adjusted
Volatility
Lyka Labs
-50.84%
-1.42
35.20%
Sensex
8.49%
0.43
11.83%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors
Factor
Value
Sales Growth (5y)
11.68%
EBIT Growth (5y)
-170.47%
EBIT to Interest (avg)
1.40
Debt to EBITDA (avg)
3.43
Net Debt to Equity (avg)
0.30
Sales to Capital Employed (avg)
0.94
Tax Ratio
100.00%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0.84%
ROCE (avg)
16.68%
ROE (avg)
47.42%
stock-recommendationValuation
Valuation Scorecard stock-summary
stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
32
Price to Book Value
2.58
EV to EBIT
-291.01
EV to EBITDA
42.24
EV to Capital Employed
2.21
EV to Sales
2.17
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
2.22%
ROE (Latest)
2.02%
Loading Valuation Snapshot...
stock-recommendationTechnicals
Technical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
Bearish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bearish
Mildly Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Bearish
Dow Theory
Mildly Bearish
Mildly Bearish
OBV
No Trend
No Trend
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
stock-recommendationFinancial Trend
Financial Trend Scorecard stock-summary
stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

0What is working for the Company
Icon
NO KEY POSITIVE TRIGGERS
-8What is not working for the Company
PBT LESS OI(Q)

At Rs -1.32 cr has Fallen at -148.18%

PAT(Q)

At Rs 0.00 cr has Fallen at -100.0%

NET SALES(Q)

Lowest at Rs 30.73 cr

Loading Valuation Snapshot...
Here's what is not working for Lyka Labs
Profit Before Tax less Other Income (PBT) - Quarterly
At Rs -1.32 cr has Fallen at -148.18%
Year on Year (YoY)
MOJO Watch
Near term PBT trend is very negative

PBT less Other Income (Rs Cr)

Profit After Tax (PAT) - Quarterly
At Rs 0.00 cr has Fallen at -100.0%
Year on Year (YoY)
MOJO Watch
Near term PAT trend is very negative

PAT (Rs Cr)

Net Sales - Quarterly
Lowest at Rs 30.73 cr
in the last five quarters
MOJO Watch
Near term sales trend is negative

Net Sales (Rs Cr)

Net Sales - Quarterly
At Rs 30.73 cr has Grown at -9.08%
Year on Year (YoY)
MOJO Watch
Near term sales trend is negative

Net Sales (Rs Cr)

Non Operating Income - Quarterly
Highest at Rs 1.16 cr
in the last five quarters
MOJO Watch
Increased income from non business activities may not be sustainable

Non Operating Income